Todd M. Bluedorn - 12 Oct 2021 Form 4 Insider Report for LENNOX INTERNATIONAL INC (LII)

Signature
/s/ John D. Torres, attorney-in-fact for Mr. Todd M. Bluedorn
Issuer symbol
LII
Transactions as of
12 Oct 2021
Net transactions value
-$2,317,294
Form type
4
Filing time
14 Oct 2021, 16:13:36 UTC
Previous filing
09 Sep 2021
Next filing
08 Dec 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LII Common Stock, Par Value $0.01 Per Share Options Exercise $0 +4,783 +8.8% $0.000000 59,109 12 Oct 2021 Direct
transaction LII Common Stock, Par Value $0.01 Per Share Options Exercise $0 +2,452 +4.1% $0.000000 61,561 12 Oct 2021 Direct
transaction LII Common Stock, Par Value $0.01 Per Share Options Exercise $0 +549 +0.89% $0.000000 62,110 12 Oct 2021 Direct
transaction LII Common Stock, Par Value $0.01 Per Share Tax liability $557,147 -1,882 -3% $296.04 60,228 12 Oct 2021 Direct
transaction LII Common Stock, Par Value $0.01 Per Share Tax liability $285,679 -965 -1.6% $296.04 59,263 12 Oct 2021 Direct
transaction LII Common Stock, Par Value $0.01 Per Share Tax liability $63,945 -216 -0.36% $296.04 59,047 12 Oct 2021 Direct
transaction LII Common Stock, Par Value $0.01 Per Share Sale $219,924 -740 -1.3% $297.19 58,307 13 Oct 2021 Direct F1, F2
transaction LII Common Stock, Par Value $0.01 Per Share Sale $26,295 -88 -0.15% $298.81 58,219 13 Oct 2021 Direct F3
transaction LII Common Stock, Par Value $0.01 Per Share Sale $167,595 -558 -0.96% $300.35 57,661 13 Oct 2021 Direct F4
transaction LII Common Stock, Par Value $0.01 Per Share Sale $30,419 -101 -0.18% $301.18 57,560 13 Oct 2021 Direct F5
transaction LII Common Stock, Par Value $0.01 Per Share Sale $44,581 -150 -0.26% $297.21 57,410 13 Oct 2021 Direct F6
transaction LII Common Stock, Par Value $0.01 Per Share Sale $11,936 -40 -0.07% $298.41 57,370 13 Oct 2021 Direct F7
transaction LII Common Stock, Par Value $0.01 Per Share Sale $16,188 -54 -0.09% $299.78 57,316 13 Oct 2021 Direct F8
transaction LII Common Stock, Par Value $0.01 Per Share Sale $24,050 -80 -0.14% $300.62 57,236 13 Oct 2021 Direct F9
transaction LII Common Stock, Par Value $0.01 Per Share Sale $2,712 -9 -0.02% $301.30 57,227 13 Oct 2021 Direct
transaction LII Common Stock, Par Value $0.01 Per Share Sale $349,296 -1,175 -2.1% $297.27 56,052 13 Oct 2021 Direct F10
transaction LII Common Stock, Par Value $0.01 Per Share Sale $119,373 -400 -0.71% $298.43 55,652 13 Oct 2021 Direct F11
transaction LII Common Stock, Par Value $0.01 Per Share Sale $240,493 -802 -1.4% $299.87 54,850 13 Oct 2021 Direct F12
transaction LII Common Stock, Par Value $0.01 Per Share Sale $157,661 -524 -0.96% $300.88 54,326 13 Oct 2021 Direct F13

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LII Non-qualified Stock Appreciation Right Options Exercise $0 -8,921 -50% $0.000000 8,921 12 Oct 2021 Common Stock, Par Value $0.01 Per Share 8,921 $214.63 Direct F14, F15
transaction LII Non-qualified Stock Appreciation Right Options Exercise $0 -15,649 -100% $0.000000* 0 12 Oct 2021 Common Stock, Par Value $0.01 Per Share 15,649 $205.53 Direct F14, F16
transaction LII Non-qualified Stock Appreciation Right Options Exercise $0 -4,174 -20% $0.000000 16,699 12 Oct 2021 Common Stock, Par Value $0.01 Per Share 4,174 $257.08 Direct F14, F17
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These sales (collectively) were effected pursuant to a Rule 10b5-1 trading plan.
F2 Reflects a weighted average sale price of $297.194 at prices ranging from $296.76 to $297.59 per share. The Reporting Person will provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
F3 Reflects a weighted average sale price of $298.810 at prices ranging from 298.80 to $298.91 per share. The Reporting Person will provide, upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
F4 Reflects a weighted average sale price of $300.349 at prices ranging from $299.92 to $300.91 per share. The Reporting Person will provide, upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
F5 Reflects a weighted average sale price of $301.182 at prices ranging from $301.15 to $301.19 per share. The Reporting Person will provide, upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
F6 Reflects a weighted average sale price of $297.208 at prices ranging from $296.85 to $297.51 per share. The Reporting Person will provide, upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
F7 Reflects a weighted average sale price of $298.410 at prices ranging from $298.02 to $298.80 per share. The Reporting Person will provide, upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
F8 Reflects a weighted average sale price of $299.783 at prices ranging from $299.20 to $300.17 per share. The Reporting Person will provide, upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
F9 Reflects a weighted average sale price of $300.619 at prices ranging from $300.20 to $301.03 per share. The Reporting Person will provide, upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
F10 Reflects a weighted average sale price of $297.273 at pricing ranging from $296.85 to $297.81 per share. The Reporting Person will provide, upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
F11 Reflects a weighted average sale price of $298.432 at prices ranging from $298.03 to $298.85 per share. The Reporting Person will provide, upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
F12 Reflects a weighted average sale price of $299.867 at prices ranging from $299.34 to $300.31 per share. The Reporting Person will provide, upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
F13 Reflects a weighted average sale price of $300.88 at prices ranging from $300.50 to $301.18 per share. The Reporting Person will provide, upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
F14 This exercise was affected pursuant to a Rule 10b5-1 trading plan.
F15 One third of the Stock Appreciation Rights became exercisable on 12/7/2019 and each year thereafter. The entire grant will become fully exercisable on 12/7/2021.
F16 One third of the Stock Appreciation Rights became exercisable on 12/8/2018 and each year thereafter. The entire grant became fully exercisable on 12/8/2020.
F17 One third of the Stock Appreciation Rights became exercisable on 12/13/2020 and each year thereafter. The entire grant will become fully exercisable on 12/13/2022.